Intro

This chapter delves into idiopathic intracranial hypertension (IIH), focusing on the potential role of glucagon-like peptide 1 (GLP-1) receptor agonists in its treatment. The discussion emphasizes the importance of proper diagnosis and timely intervention to avert long-term complications.